Algert Global’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-51,413
Closed -$1.35M 374
2017
Q2
$1.35M Buy
+51,413
New +$1.26M 0.38% 122
2016
Q1
Sell
-17,740
Closed -$621K 425
2015
Q4
$621K Buy
17,740
+3,870
+28% +$121K 0.29% 131
2015
Q3
$395K Sell
13,870
-6,850
-33% -$230K 0.22% 176
2015
Q2
$690K Buy
20,720
+170
+0.8% +$5.22K 0.38% 95
2015
Q1
$579K Buy
+20,550
New +$511K 0.32% 119
2014
Q2
Sell
-44,566
Closed -$1.25M 372
2014
Q1
$1.25M Sell
44,566
-49,340
-53% -$1.21M 0.49% 63
2013
Q4
$2.02M Buy
93,906
+16,480
+21% +$300K 0.54% 60
2013
Q3
$1.03M Buy
77,426
+36,820
+91% +$496K 0.3% 128
2013
Q2
$563K Buy
+40,606
New +$575K 0.17% 180

Other funds holding PMC

Algert Global's PMC Position: Q3 2017 in Review

Algert Global sold out of PharMerica Corporation (PMC) in Q3 2017, closing a stake of 51,413 shares — an estimated $1.35M sold.

Algert Global first reported a position in PMC in Q2 2013 and held it in 9 quarters. The position peaked at $2.02M in Q4 2013. 150 funds tracked by Wall St. Rank hold PMC as of Q3 2017.

  • Algert Global reported no remaining PharMerica Corporation position as of Q3 2017 after selling out during the quarter.
  • Algert Global sold 51,413 PharMerica Corporation shares in Q3 2017, an estimated $1.35M.
  • Algert Global first reported a position in PharMerica Corporation in Q2 2013 and held it in 9 quarters.
  • Algert Global's PharMerica Corporation position peaked at $2.02M in Q4 2013.
  • 150 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2017.

Based on Algert Global's 13F filing for Q3 2017, filed 17 Nov 2017.